MOR-14

N/A

Report date: 2024/01/10 15:11:47

Base Information

Drug NameMOR-14
Drug Alias NameN-methyldeoxynojirimycinN-methylmoranoline
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen activators inhibitorsAcidic alpha-glucosidase inhibitors
TargetsPlasminogen activatorsAcidic alpha-glucosidase
Therapy Area/IndicationsDiabetes MellitusReperfusion InjuryThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Shinyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusReperfusion InjuryThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A